首頁 > 市場調查報告書 > 醫療設備

病患監測體外診斷血糖監測

連續血糖監測設備市場規模、佔有率和成長分析（按組件、連接類型、最終用途和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1902941

連續血糖監測設備市場規模、佔有率和成長分析（按組件、連接類型、最終用途和地區分類）—產業預測（2026-2033 年）

Continuous Glucose Monitoring Devices Market Size, Share, and Growth Analysis, By Component (Transmitters, Sensors), By Connectivity (Bluetooth, 4G), By End-use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，持續血糖監測市場規模將達到 98.4 億美元，到 2025 年將達到 111.7 億美元，到 2033 年將達到 307.6 億美元，在預測期（2026-2033 年）內，複合年成長率為 13.5%。

糖尿病盛行率的不斷攀升，以及持續血糖監測（CGM）設備的日益普及，推動了市場顯著成長。糖尿病影響全球數百萬人，CGM設備正成為糖尿病管理的重要工具，能夠提供有關飲食習慣、藥物依從性、運動量和整體健康狀況的重要資訊。數位化治療解決方案的開發正在加強製造商與患者之間的合作，促進更全面的糖尿病管理方法。目前，眾多應用程式能夠有效利用CGM數據來識別趨勢並建議生活方式的改變。這些創新功能不僅有助於患者管理自身健康，也顯著推動了CGM設備市場的成長，凸顯了其在糖尿病照護中日益重要的角色。

持續血糖監測設備市場促進因素

全球糖尿病盛行率的不斷上升是推動有效監測和管理工具（例如持續血糖監測設備）需求的主要因素。隨著越來越多的患者被診斷出患有這種慢性疾病，可靠、即時地追蹤血糖值變得至關重要。這些設備能夠幫助患者及時調整治療方案，進而增強其健康管理能力，並有助於全面改善糖尿病管理。人們對更健康、更高品質生活的追求也進一步推動了市場成長，他們尋求創新的解決方案來維持最佳血糖值並預防糖尿病相關併發症。

限制連續血糖監測設備市場的因素

儘管連續血糖監測設備的準確性有所提高，但與傳統血糖檢測法相比，仍存在一些偏差。這種差異可能導致使用者對測量結果可靠性產生擔憂，進而影響使用者對這項技術的信任度和接受度。因此，有些人更傾向於依賴傳統方法，尤其是在緊急情況下，準確的血糖值對於健康管理至關重要。這種對全面接受連續血糖監測的猶豫態度可能會阻礙這些創新設備在市場上的廣泛應用。

連續血糖監測設備市場趨勢

持續血糖監測（CGM）設備市場正呈現與數位健康平台日益融合的明顯趨勢，顯著提升了使用者體驗和資料管理效率。這種融合使用戶能夠輕鬆監測血糖值及其他健康指標，從而實現更全面的個人健康管理。隨著對科技主導健康解決方案的需求不斷成長，CGM設備正發展成為提供即時數據分析的先進工具，幫助使用者積極調整生活方式，改善糖尿病管理。這一趨勢反映了醫療保健系統向互聯互通的更廣泛轉變，在這個系統中，數據協同效應使用戶能夠做出明智的健康決策，並獲得更好的健康結果。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Abbott Laboratories（USA）
Dexcom, Inc.（USA）
Medtronic PLC（Ireland）
Roche（Switzerland）
Senseonics Holdings, Inc.（USA）
GlySens Incorporated（USA）
Novo Nordisk A/S（Denmark）
Insulet Corporation（USA）
Tandem Diabetes Care, Inc.（USA）
Ascensia Diabetes Care Holdings AG（Switzerland）
Ypsomed AG（Switzerland）
Menarini Diagnostics（Italy）
Nemaura Medical Inc.（UK）
Medisana GmbH（Germany）
Sanofi（France）
Johnson & Johnson（USA）
Braun Melsungen AG（Germany）
Arkray, Inc.（Japan）
Terumo Corporation（Japan）
MicroTech Medical（China）

結論與建議

簡介目錄

Product Code: SQMIG35A2568

Continuous Glucose Monitoring Devices Market size was valued at USD 9.84 Billion in 2024 and is poised to grow from USD 11.17 Billion in 2025 to USD 30.76 Billion by 2033, growing at a CAGR of 13.5% during the forecast period (2026-2033).

The rising prevalence of diabetes, coupled with the increasing adoption of continuous glucose monitoring (CGM) devices, is driving substantial market growth. With millions affected globally, CGM devices are becoming essential tools for managing diabetes, providing critical insights into dietary habits, medication adherence, physical activity, and overall health. The development of digital therapeutic solutions has enhanced connectivity between manufacturers and patients, fostering a more integrated approach to diabetes management. Numerous applications are now available, effectively leveraging CGM data to identify trends and advise on lifestyle modifications. These innovative features not only empower patients in their health journeys but also significantly contribute to the positive growth trajectory of the CGM device market, highlighting its expanding role in diabetes care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Continuous Glucose Monitoring Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Continuous Glucose Monitoring Devices Market Segments Analysis

Global Continuous Glucose Monitoring Devices Market is segmented by Component, Connectivity, End-use and region. Based on Component, the market is segmented into Transmitters, Sensors and Receivers. Based on Connectivity, the market is segmented into Bluetooth, 4G and Others. Based on End-use, the market is segmented into Hospitals and Homecare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Continuous Glucose Monitoring Devices Market

The rising global incidence of diabetes serves as a major catalyst for the demand for effective monitoring and management tools, such as continuous glucose monitoring devices. As more individuals are diagnosed with this chronic condition, the need for reliable, real-time tracking of glucose levels has become paramount. These devices offer patients enhanced control over their health by allowing for timely adjustments to their treatment plans, thereby improving overall diabetes management. The emphasis on better health outcomes and quality of life further propels the growth of this market, as individuals seek innovative solutions to maintain optimal glucose levels and prevent complications associated with diabetes.

Restraints in the Continuous Glucose Monitoring Devices Market

Despite the advancements in accuracy of continuous glucose monitoring devices, there remain instances where these devices may show occasional inconsistencies when contrasted with conventional blood glucose testing methods. This variability can lead to apprehensions among users regarding the reliability of the readings, impacting their trust and overall acceptance of the technology. As a result, some individuals may prefer to rely on traditional methods, especially in critical situations where precise glucose levels are imperative for health management. This hesitation to fully embrace continuous monitoring could hinder the broader adoption of these innovative devices within the market.

Market Trends of the Continuous Glucose Monitoring Devices Market

The Continuous Glucose Monitoring (CGM) devices market is witnessing a robust trend towards integration with digital health platforms, enhancing user experience and data management. This convergence enables individuals to effortlessly monitor their glucose levels alongside additional health metrics, promoting a more holistic approach to personal health management. As demand for technology-driven health solutions rises, CGM devices are evolving into sophisticated tools that offer real-time data insights, facilitating proactive lifestyle adjustments and improved diabetes management. This trend reflects a broader shift towards interconnected healthcare systems, where data synergy supports users in making informed health decisions and achieving better health outcomes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Technology Advancement
Regulatory Landscape
Customer & Buying Criteria Analysis
Patent Analysis

Global Continuous Glucose Monitoring Devices Market Size by Component & CAGR (2026-2033)

Market Overview
Transmitters
Sensors
Receivers

Global Continuous Glucose Monitoring Devices Market Size by Connectivity & CAGR (2026-2033)

Market Overview
Bluetooth
4G
Others

Global Continuous Glucose Monitoring Devices Market Size by End-use & CAGR (2026-2033)

Market Overview
Hospitals
Homecare

Global Continuous Glucose Monitoring Devices Market Size & CAGR (2026-2033)

North America (Component, Connectivity, End-use)
- US
- Canada
Europe (Component, Connectivity, End-use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Component, Connectivity, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Component, Connectivity, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa (Component, Connectivity, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dexcom, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Senseonics Holdings, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlySens Incorporated (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novo Nordisk A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Insulet Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tandem Diabetes Care, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ascensia Diabetes Care Holdings AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Menarini Diagnostics (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nemaura Medical Inc. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medisana GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arkray, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroTech Medical (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments